Notable Analyst Rating Changes 9/7: (LGND) (GLPI) (DIN) Upgraded; (MNTA) (OLN) (TNXP) Downgraded
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Deutsche Bank boosts Ligand Pharma (Nasdaq: LGND) from Sell to Hold and moves its price target from $110 to $105. Click Here for more color.
Morgan Stanley raises Gaming and Leisure (Nasdaq: GLPI) from Equalweight to Overweight with a price target of $38.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
Longbow Research cuts Oiln (NYSE: OLN) from Neutral to Underperform with a price target of $17.
Oppenheimer lowers Tonix Pharma (Nasdaq: TNXP) from Outperform to Perform.
BofA/Merrill Lynch trims Banco Santander Chile (NYSE: BSAC) from Buy to Underperform.
For daily real-time Downgrades go to http://www.streetinsider.com/downgrades
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Notable Analyst Rating Changes 10/24: (CHK) (VMW) (CMCSA) Upgraded; (ADAP) (TEX) (LECO) Downgraded
- 21st Century Fox (FOXA) Won't Bid for Viacom (VIAB)
- Regulators taking another look at costs of Wall Street safety rule
Create E-mail Alert Related CategoriesSpecial Reports
Related EntitiesDeutsche Bank, KeyBanc, Morgan Stanley, Merrill Lynch, Bank of America, Longbow Research, Argus, Maxim Group, Notable Analyst Rating Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!